741 deaths at Gujarat Hospital linked to unauthorised stem cell therapy, claims Congress - Video

A major controversy has erupted in Gujarat following allegations of unauthorised stem cell therapy trials being conducted for years without proper approvals at a government hospital that may be linked to the unconfirmed deaths of 741 kidney patients, as alleged by the Gujarat Congress party spokesperson Parthivrajsinh Kathavadia.

At a recent press conference, Kathavadia alleged that between 1999 and 2017, a total of 2,352 patients at the government-run Institute of Kidney Diseases and Research Centre (IKDRC) in Ahmedabad were subjected to experimental stem cell therapy. He alleged that all these data and findings have been documented in a Comptroller and Auditor General (CAG) report.

According to his claims, the Comptroller and Auditor General (CAG) report revealed that the therapy resulted in the death of 741 kidney patients, failed in 91% of the cases, with 569 patients experiencing kidney transplant failure, and complications in 110 patients prevented kidney transplants. Moreover, 2,132 out of 2,352 patients experienced unsuccessful outcomes.